INTERNATIONAL PATENT: NANJING LEADS BIOLABS CO., LTD., 南京维立志博生物科技股份有限公司 FILES APPLICATION FOR "ANTI-PD-L1 AND ANTI-4-1BB BISPECIFIC ANTIBODY FOR TREATING MALIGNANT TUMORS AND PHARMACEUTICAL COMBINATION THEREOF"

Posted On: 2026-03-29

GENEVA, March 29 -- NANJING LEADS BIOLABS CO., LTD. (Building 5, 122 Huakang Road, Jiangbei New AreaNanjing, Jiangsu 210031), 南京维立志博生物科技股份有限公司 (中国江苏省南京市江北新区华康路122号加速器四期05栋) filed a patent application (PCT/CN2025/123291) for "ANTI-PD-L1 AND ANTI-4-1BB BISPECIFIC ANTIBODY FOR TREATING MALIGNANT TUMORS, AND PHARMACEUTICAL COMBINATION THEREOF" on Sep 23, 2025. With publication no. WO/2026/061538, the details related to the patent application was published on Mar 26, 2026.

Notably, t...

Click here to read full article from source

इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया हमे संपर्क करें.

विशेष

Category

Source

Publication

Location

INTERNATIONAL PATENT: NANJING LEADS BIOLABS CO., LTD., 南京维立志博生物科技股份有限公司 FILES APPLICATION FOR "ANTI-PD-L1 AND ANTI-4-1BB BISPECIFIC ANTIBODY FOR TREATING MALIGNANT TUMORS AND PHARMACEUTICAL COMBINATION THEREOF"